Skip to main content
Call 24/7: 1-800-400-1805
1-800-400-1805 Free Case Review
Sign In Join Free

ttfields for lung cancer vs meso - why the distinction actually matters

Family · · 36 views
So I got asked this at work yesterday by a colleague whose sister has lung cancer, and I realized I'd never actually looked into whether tumor treating fields work the same way for regular lung cancer as they do for meso. Made me think about my dad's case again.

Honestly the answer is kind of complicated. TTFields got FDA approval for glioblastoma first, then for mesothelioma, but the lung cancer approval is... different. There's research happening, clinical trials running, but it's not standard of care for non-meso lung cancer the way it is for pleural meso right now.

The thing that gets me is how specific the science has to be. Meso cells behave differently than regular adenocarcinoma or squamous cell lung cancer, so the electrical fields that disrupt meso cell division don't necessarily work the same way on other lung cancers. It's not like one device fits all lung pathology.

My dad's oncologist at Northwestern mentioned this back in September when we were looking at all his options. She was pretty clear that TTFields made sense for his stage IV pleural specifically because of how much data we have on meso response, versus if he'd had conventional lung cancer it would've been a totally different conversation about clinical trials and what's actually proven.

If someone's asking because they have lung cancer that's not meso, I'd say talk to their team about clinical trials in their area. The field is moving fast but it's not the same established option yet. But for meso? Yeah, it's worth serious consideration.

9 Replies

Family
yeah my mom's oncologist brought up ttfields too and explained it pretty much the same way, like it's actually approved for meso but they're still figuring it out for regular lung cancer. good to see someone breaking down why the difference matters instead of just lumping them together.
Family
That's so good that her oncologist laid it out clearly for you like that. A lot of people don't realize how much the cellular biology actually drives the treatment options, and it sounds like your mom's team gets it. How far along is your mom in her treatment right now?
Family
You're hitting on something really important here. The cellular biology piece is exactly why I got frustrated when I was researching options for my dad back in spring. Everyone kept saying "oh there's this device" without really understanding that the physics of how TTFields work depends on tumor morphology and how cells are organized.

With mesothelioma you're dealing with mesothelial cells that have specific electrical properties, and the fields are calibrated around that. Conventional lung cancers are just... different architecturally. The cells respond differently to the same electrical gradient. It's not a limitation of TTFields so much as it's evidence-based medicine actually working the way it should.

My dad never ended up doing TTFields anyway because by the time we got to that conversation in September he was declining faster than expected, and his oncologist at Northwestern felt palliative care was the better path given his overall status. But I remember asking about it specifically for pleural meso and she was really confident the data supported it, whereas she said if we were looking at regular adenocarcinoma the conversation would be "let's get you enrolled in a trial."

The clinical trial angle is huge for people without meso. There's legitimately good research happening right now but it's not the same as having level one evidence the way we do for mesothelioma. Your colleague's sister should absolutely ask her team about open trials in her area. Things move fast in this space.
Patient
yeah this is real helpful stuff. my oncologist at Henry Ford brought up TTFields back when we were doing the surgery planning in January, and honestly I didn't understand half of what she said at first. but then she walked me thru how the fields work on meso cells specifically and it clicked why it matters that my cancer isn't just "lung cancer" you know.

the way she explained it, regular lung cancer and meso are like different engine problems. you wouldn't use the same fix for both. made sense coming from a mechanic background honestly. so when my buddy mentioned his neighbor had regular lung cancer and asked if I'd recommend TTFields, I had to tell him that's a whole different ballgame and his neighbor should be talking to their doctors about what's actually proven for their specific type.

I'm doing the follow-up with chemo now after the EPP back in February and so far so good. no TTFields yet but doc said we'll see how things go. the fact that there's all this research happening for other lung cancers is cool tho, means the science keeps moving. just not there yet for non-meso like it is for us.

your dad's lucky he had that Northwestern team being straight with him about what works and what doesn't. a lot of people get confused thinking all lung cancer is the same thing.
Veteran
Got my oncology team at UC San Diego pushing TTFields hard right now, stage II pleural. Surgery in December cleared out what they could but the docs are pretty firm that fields are part of the standard play for meso specifically. Your dad's oncologist is right on it.

The thing that pisses me off is how long it took to get here. I was exposed at Camp Lejeune back in 1980 and then again on the Iwo Jima, asbestos in the insulation everywhere, and nobody connected those dots until I couldn't breathe anymore in October. By then it's already stage II. If they'd had this tech available thirty years ago or if the Navy had actually dealt with the contamination instead of covering it up... anyway. That's a different fight.

But yeah the distinction matters. Meso cells are weird, they respond to the electrical stimulation in ways lung cancer cells don't necessarily. My oncologist explained it like the tumor types have different electrical properties or whatever the technical term is. The clinical data for meso is solid enough now that it's not experimental anymore, just standard treatment. Lung cancer? Still in the trial phase for most of it.

Your colleague's sister should definitely ask her team about trials in her area if they think she's a candidate. But if she's got meso instead, tell her to push her doctors hard on TTFields. Don't let them talk around it. It's one of the few things that actually seems to make a difference.
Veteran
Got my TTFields vest fitted in January after the surgery. Doc at Naval Medical Center San Diego brought it up pretty quick once they confirmed the pleural diagnosis. He was straight with me about it, said the data on meso response is solid compared to regular lung cancer, which is still mostly in trials for non-meso cases.

Your dad's situation at Northwestern sounds right. The oncologists aren't being cagey about it, they just know TTFields works different depending on what you're actually fighting. Meso's this specific beast and the treatment has to match. Regular lung cancer is a whole other animal.

What I'm dealing with now is the vest itself. It's annoying as hell, not gonna lie. Wires everywhere, gotta charge it, can't shower with it on, and the pads irritate your skin if you're not careful about rotation. But I'm three months in and my oncologist says we're seeing what we want to see on the scans. So I'm doing it. That's the part nobody talks about though, the actual wearing of the damn thing day in and day out. Clinical trial data doesn't really capture that part.

Your colleague's sister should definitely push her team on whether there's a trial she qualifies for in her area. The field's moving fast but yeah, not standard yet for non-meso. Meso folks are the proof of concept right now.
Medical ✓ Expert Response
What your dad's oncologist said tracks with what I've seen in my work with patients over the years. The biology really does matter here. Meso has this unusual growth pattern along the pleural lining, and the frequency settings that have been studied for meso aren't just transferable to, say, an adenocarcinoma in the lung parenchyma. Different tumor architecture, different cell division dynamics.

The STELLAR trial data was pretty striking when it came out, showing median overall survival around 18 months for meso patients on TTFields plus chemo, which was genuinely meaningful for a disease where we've had so few options. But that data is meso-specific. Your colleague's sister would be looking at a completely different evidence landscape if she has conventional lung cancer, and honestly her oncologist would need to walk her through what trials are actually enrolling right now in her area.

Something I've noticed in my support groups is that families sometimes hear "TTFields" as one thing and don't realize how condition-specific the approvals and the science are. The conversation you had with your dad's team in September sounds like exactly the right approach, really drilling down on what the evidence actually supports for his specific diagnosis.

And I'll say this gently... carrying your dad's case in your mind while also trying to help a colleague is a lot. That kind of empathy is real, but so is the emotional weight of it. If that's sitting heavier than you expected, talking to someone outside the situation can help.
2 found this helpful
Family
Joe's team at Moffitt actually walked us through this same thing back in November when we were starting the immunotherapy, and honestly it helped me understand why they weren't even mentioning clinical trials for his pleural meso. They showed us these cell images and explained how the mesothelioma cells are shaped so differently that the TTFields can actually disrupt their division in a way that just doesn't translate to regular lung cancer cells. It's like teaching different grade levels, you know? You can't use the same lesson plan for kindergarten and high school and expect it to work the same way.

What I don't think gets talked about enough is that even though TTFields is approved for meso, not every oncology center has the equipment or the expertise to manage it well. We had to drive out to Moffitt because our local hospital wasn't set up for it. So even if someone's got meso and it's technically an option, logistics matter too...

How's your dad doing now with his treatment plan?
Family
Yeah, the cell morphology piece is exactly it. I've seen those same images Northwestern pulled up for my dad and it's wild how different they look under the microscope. The way meso cells are structured with that mesothelial origin just makes them way more susceptible to the electrical disruption than typical lung adenocarcinoma would be.

And honestly? It sounds like Moffitt's team really took the time to explain the science to you guys, which I think makes such a difference. When you understand the "why" behind treatment decisions it's less scary somehow, or at least it was for me with my dad. Are they still considering TTFields as part of Joe's protocol or did the immunotherapy seem like the better path for him?

Share Your Experience

Sign in or create a free account to share your experience.

Sign In Create Account

Discussions in this community are for informational and emotional support purposes only. They do not constitute legal advice, medical advice, or an attorney-client relationship. Always consult a qualified professional for advice specific to your situation. Community Guidelines

Call Now: (800) 400-1805 Free Case Review • Available 24/7